A randomized, double-blind study comparing a fixed dose combination of telmisartan 40 mg plus hydrochlorothiazide 12.5 mg to telmisartan 40 mg in patients who fail to respond adequately to treatment with telmisartan 40 mg

Trial Profile

A randomized, double-blind study comparing a fixed dose combination of telmisartan 40 mg plus hydrochlorothiazide 12.5 mg to telmisartan 40 mg in patients who fail to respond adequately to treatment with telmisartan 40 mg

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Nov 2013

At a glance

  • Drugs Telmisartan; Telmisartan/hydrochlorothiazide
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Nov 2007 Status changed from in progress to completed.
    • 15 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top